Abstract
Background
Herpesviruses are widespread viruses, causing severe infections in both humans and animals. Eradication of herpesviruses is extremely difficult because of their ability to establish latent and life-long infections. However, latency is only one tool that has evolved in herpesviruses to successfully infect their hosts; such viruses display a wide (and still incompletely known) panoply of genes and proteins that are able to counteract immune responses of their hosts. Envelope glycoproteins and cytokine inhibitors are two examples of such weapons. All of these factors make it difficult to develop diagnostics and vaccines, unless they are based on molecular techniques.
Materials and Methods
Animal herpesviruses, because of their striking similarity to human ones, are suitable models to study the molecular biology of herpesviruses and develop strategies aimed at designing neurotropic live vectors for gene therapy as well as engineered attenuated vaccines.
Results
BHV-1 is a neurotropic herpesvirus causing infectious rhinotracheitis (IBR) in cattle. It is a major plague in zootechnics and commercial trade, because of its ability to spread through asymptomatic carrier animals, frozen semen, and embryos. Such portals of infections are also important for human herpesviruses, which mainly cause systemic, eye, and genital tract infections, leading even to the development of cancer.
Conclusions
This review covers both the genetics and molecular biology of BHV-1 and its related herpesviruses. Epidemiology and diagnostic approaches to herpesvirus infections are presented. The role of herpesviruses in gene therapy and a broad introduction to classic and engineered vaccines against herpesviruses are also provided.
Similar content being viewed by others
References
Metzler AE, Matile H, Gassmann U, Engels M, Wyler E. (1985) European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides and reactivity with monoclonal antibodies. Arch. Virol. 85: 57–69.
Misra V, Babiuk LA, Darcel CQ. (1983) Analysis of bovine herpesvirus type 1 isolates by restriction endonuclease fingerprinting. Arch. Virol. 76: 341–354.
Engels M, Steck F, Wyler R. (1981) Comparison of the genomes of infectious bovine rhinotracheitis and infectious pustolar vulvovaginitis virus strains by restriction endonuclease analysis. Arch. Virol. 67: 169–174.
Whetstone CA, Seal BS, Miller JM. (1993) Variability occurs in the inverted repeat region of genomic DNA from bovine herpesvirus 1 respiratory, genital and bovine herpesvirus 5 encephalitic isolates. Vet. Microbiol. 38: 181–189.
Seal BS, Whetstone CA. (1994) Immediate-early gene expression and gene mapping comparisons among isolates of bovine herpesvirus 1 and 5. Vet. Microbiol. 38: 369–384.
Bratanich AC, Sardi SI, Smitsaart EN, Schudel AA. (1991) Comparative studies of BHV-1 variants by in vivo-in vitro tests. J. Vet. Med. B 38: 41–48.
Mayfield JE, Good PJ, van Oort HJ, Campbell AR, Reed DE. (1983) Cloning and cleavage site mapping of DNA from bovine herpesvirus 1 (cooper strain). J. Virol. 47: 259–264.
Castrucci G, Frigeri F, Ranucci S, et al. (1984) Comparative studies of strains of infectious bovine rhinotracheitis virus isolated from latently infected calves. Comp. Immunol. Microbiol. Infect. Dis. 7: 1–10.
Engels M, Ackermann M. (1996) Pathogenesis of ruminant herpesvirus infections. Vet. Microbiol. 53: 3–15.
Yates DWG. (1982) A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46: 225–263.
van Oirschot JT. (1995) Bovine herpesvirus 1 in semen of bulls and the risk of transmission: a brief review. Vet. Q. 17: 29–33.
Misra PK, Mishra A. (1987) Infectious bovine rhinotracheitis infection and infertility in cows, heifers and bulls. Indian J. Anim. Sci. 57: 267–271.
Parsonson IM, Snowdon WA. (1975) The effect of natural and artificial breeding using bulls infected with, or semen contaminated with, infectious bovine rhinotracheitis virus. Aust. Vet. J. 51: 365–369.
Bielanski A, Loewen KG, Hare WCD. (1988) Inactivation of bovine herpesvirus-1 (BHV-1) from in vitro infected bovine semen. Theriogenology 30: 649–657.
Wyler R, Engels M, Schwyzer M. (1989) Infectious bovine rhinotracheitis/vulvovaginitis (BHV-1). In: Wittman G (ed). Herpesvirus Diseases of Cattle, Horses and Pigs. Kluwer Academic Publishers, Boston, pp.1–72.
Thiry E, Saliki J, Pastoret P-P, Lambert A-F, Ligot J. (1984) Failure to demonstrate infectious bovine rhinotracheitis virus reactivation in parturient cows. Vet. Rec. 8: 248–249.
Van Wuijckhuise L, Bosch J, Franken P, Frankena K, Elbers ARW. (1998) Epidemiological characteristics of bovine herpesvirus 1 infections determined by bulk milk testing of all Dutch dairy herds. Vet. Rec. 142: 181–184.
Pastoret P-P, Thiry E. (1985) Diagnosis and prophylaxis of infectious bovine rhinotracheitis: the role of virus latency. Comp. Immun. Microbiol. Infect. Dis. 8: 35–42.
Thiry E, Saliki J, Bublot M, Pastoret P-P. (1987) Reactivation of infectious bovine rhinotracheitis virus by transport. Comp. Immun. Microbiol. Infect. Dis. 10: 59–63.
Geng Y, Kashanchi F, Wood C. (1992) Activation of bovine immunodeficiency-like virus expression by bovine herpesvirus type 1. Virology 187: 832–836.
Arthington JD, Corah LR, Blecha F. (1996) The effect of molybdenum-induced copper deficiency on acute-phase protein concentrations, superoxide dismutase activity leukocyte numbers, and lymphocyte proliferation in beef heifers inoculated with bovine herpesvirus-1. J. Anim. Sci. 74: 211–217.
Hage JJ, Schukken YH, Barkema HW, Benedictus G, Rijsewjk FAM, Wentink GH. (1996) Population dynamics of bovine herpesvirus 1 infection in a dairy herd. Vet. Microbiol. 53: 169–180.
Tanyi J, Varga J. (1992) Guidelines for the eradication of bovine rhinotracheitis in Hungary. Acta Vet. Hung. 40: 165–169.
Homan EJ, Easterday BC. (1980) Isolation of bovine herpesvirus-1 from trigeminal ganglia of clinically normal cattle. Am. J. Vet. Res. 41: 1212–1213.
Ackerman M, Peterhans E, Wyler R. (1982) DNA of bovine herpes virus type 1 in the trigeminal ganglia of latently infected calves. Am. J. Vet. Res. 43: 36–40.
Drew TW, Hewitt-Taylor C, Watson L, Edwards S. (1987) Effect of storage conditions and culture technique on the isolation of infectious bovine rhinotracheitis virus from bovine semen. Vet. Rec. 121: 547–548.
Loewen KG, Darcel C. (1985) A comparison of two methods for the isolation of bovine herpesvirus 1 (BHV-1) from extended bovine semen. Theriogenology 23: 935–943.
Brunner D, Engels M, Schwyzer M, Wyler R. (1988) A comparison of three techniques for detecting bovine herpesvirus type 1 (BHV-1) in naturally and experimentally contaminated semen. Zuchthung 23: 1–9.
Wentink GH, Rutten VPMG, van Exel ACA, De Jong WAC, Vleugel H, Hensen EJ. (1990) Failure of an in vitro lymphoproliferative assay specific for bovine herpesvirus type 1 to detect immunized or latently infected animals. Vet. Q. 12: 175–182.
Florent G, De Marneffe C. (1986) Enzyme linked immunosorbent assay used to monitor serum antibodies to bovine respiratory disease viruses. Vet. Microbiol. 11: 307–317.
Edwards S, Woods SB, Westcott DG, Emmerson M, Jones PC, Phillips AJ. (1986) An evaluation of five serological tests for the detection of antibody to bovine herpesvirus 1 in vaccinated and experimentally infected cattle. Res. Vet. Sci. 41: 378–382.
Kramps JA, Quak S, Weer Dmeester K, van Oirschot JT. (1993) Comparative study on sixteen enzyme-linked immunosorbent assays for the detection of antibodies to bovine herpesvirus 1 in cattle. Vet. Microbiol. 35: 11–21.
Derget D, Cho HJ, Kozub GC. (1993) A comparative evaluation of two sensitive serum neutralizing tests for bovine herpes-1 antibodies. Can. J. Vet. Res. 57: 56–59.
Abdelmagid OY, Mansour MM, Minocha HC, van Drunen Littel-van den Hurk S. (1998) Evaluation of baculovirus-expressed bovine herpesvirus-1 (BHV-1) glycoproteins for detection and analysis of BHV-1-specific antibody responses. Vet. Microbiol. 61: 249–259.
Kramps JA, Perrin B, Edwards S, van Oirschot JT. (1996) A European inter-laboratory trial to evaluate the reliability of serological diagnosis of bovine herpesvirus 1 infections. Vet. Microbiol. 53: 153–161.
van Donkersgoed J, Babiuk L. (1991) Diagnosing and managing the respiratory form of infectious bovine rhinotracheitis. Vet. Med. 1: 86–94.
Andino RH, Torres HN, Polacino PS, Schudel A, Palma EL. (1987) Detection of bovine herpesvirus-1 nucleic acid sequences, using a dot-blot hybridization procedure. Am. J. Vet. Res. 48: 984–987.
Vilcek S, Deliova I, Forgac O, et al. (1993) Detection of bovine herpesvirus 1 with various types of DNA probes. Acta Vet. Hung. 41: 179–190.
van Engelenburg FAC, van Schie FW, Rijsewijk FAM, van Oirschot JT. (1995) Excretion of bovine herpesvirus 1 in semen is detected much longer by PCR than by virus isolation. J. Clin. Microbiol. 33: 308–312.
Kibenge FSB, Harris LM, McKenna PK, Wadowska D, Yason CV. (1994) Amplification of strains of bovine herpesvirus 1 by use of polymerase chain reaction with primers in the thymidine kinase region. Am. J. Vet. Res. 55: 1206–1212.
Yason CV, Harris LM, McKenna PK, Wadowska D, Kibenge FSB. (1995) Establishment of conditions for the detection of bovine herpesvirus-1 by polymerase chain reaction using primers in the thymidine kinase region. Can. J. Vet. Res. 59: 94–101.
Vilcek S, Nettleton PF, Herring JA, Herring AJ. (1994) Rapid detection of bovine herpesvirus 1 (BHV 1) using the polymerase chain reaction. Vet. Microbiol. 42: 53–64.
van Engelenburg FAC, Maes RK, van Oirschot JT, Rijsewijk FAM. (1993) Development of a rapid and sensitive polymerase chain reaction assay for detection of bovine herpesvirus type 1 in bovine semen. J. Clin. Microbiol. 31: 3129–3135.
Wiedmann M, Brandon R, Wagner P, Dubovi EJ, Batt CA. (1993) Detection of bovine herpesvirus-1 in bovine semen by a nested PCR assay. J. Virol. Methods 44: 129–140.
Masri SA, Olson W, Nguyen PT, Prins S, Deregt D. (1996) Rapid detection of bovine herpesvirus 1 in the semen of infected bulls by a nested polymerase chain reaction assay. Can. J. Vet. Res. 60: 100–107.
Asbaugh SE, Thompson KE, Belknap EB, Schultheiss PC, Chowdhury S, Collins JK. (1997) Specific detection of shedding and latency of bovine herpesvirus 1 and 5 using a nested polymerase chain reaction. J. Vet. Diagn. Invest. 9: 387–394.
Lyaku JRS, Vilcek S, Nettieton PF, Marsden HS. (1996) The distinction of serologically related ruminant alphaherpesviruses by the polymerase chain reaction (PCR) and restriction endonuclease analysis. Vet. Microbiol. 48: 135–142.
Rusvai M, Fodor L. (1998) Occurrence of some viruses and bacteria involved in respiratory diseases of ruminants in Hungary. Acta Vet. Hung. 46: 405–414.
Schwyzer M, Ackermann M. (1996) Molecular virology of ruminant herpesviruses. Vet. Microbiol. 53: 17–29.
Tikoo SK, Fitzpatrick DR, Babiuk LA, Zamb TJ. (1990) Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J. Virol. 64: 5132–5142.
Tikoo SK, Zamb TJ, Babiuk LA. (1993) Analysis of bovine herpesvirus 1 glycoprotein gIV truncation and deletions expressed by recombinant vaccinia viruses. J. Virol. 67: 2103–2109.
Chase CCL, Lohff C, Letchworth GJ. (1993) Resistance and susceptibility of bovine cells expressing herpesviral glycoprotein D homologous to herpesviral infections. Virology 194: 365–369.
Baranowski E, Keil G, Lyaku J, et al. (1996) Structural and functional analysis of bovine herpesvirus 1 minor glycoproteins. Vet. Microbiol. 53: 91–101.
Liang X, Babiuk LA, Zamb TJ. (1992) An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing β-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology 189: 629–639.
Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. (1998) Entry of alpha herpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280: 1618–1620.
Montgomery RI, Warner MW, Lum BJ, Spear PG. (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427–436.
Li Y, van Drunen Littel-van den Hurk S, Babiuk LA, Liang X. (1995) Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C and D: identification of a dual cell-binding function of gB. J. Virol. 68: 4758–4768.
Varthakavi V, Minocha HC. (1996) Identification of a 56 kDa putative bovine herpesvirus 1 cellular receptor by anti-idiotype antibodies. J. Gen. Virol. 77: 1875–1882.
Liang X, Pyne C, Li Y, Babiuk LA, Kowalski J. (1995) Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry. Virology 207: 429–441.
Spear PG. (1993) Entry of alphaherpesviruses into cells. Semin. Virol. 4: 167–180.
Ludwig GV, Letchworth G. (1987) Temporal control of bovine herpesvirus 1 glycoproteins synthesis. J. Virol. 61: 3292–3294.
Misra V, Bumenthal RM, Babiuk LA. (1981) Proteins specified by bovine herpesvirus 1 (infectious rhinotracheitis virus). J. Virol. 40: 367–378.
Fitzpatrick DR, Babiuk LA, Zamb TJ. (1989) Nucleotide sequence of bovine herpesvirus type 1 glycoprotein gIII, a structural model for gIII as a new member of the immunoglobulin superfamily, and implications for the homologous glycoproteins of other herpesviruses. Virology 173: 46–57.
Liang X, Babiuk L, Zamb T. (1991) Pseudorabies virus gIII and bovine herpesvirus I gIII share complementary functions. J. Virol. 65: 5553–5557.
Liang X, Tang M, Zamb TJ, Babiuk LA, Kowalski J, Tykocinski ML. (1993) Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor. J. Virol. 67: 4896–4904.
Liang X, Babiuk LA, Zamb TJ. (1993) Mapping of heparin-binding structures on bovine herpesvirus 1 and Pseudorabies virus gIII glycoproteins. Virology 194: 233–243.
Roizman B, Desroisiers R, Fleckenstein B. (1992) The family Herpesviridae: an update. Arch. Virol. 123: 425–449.
Whitbeck JC, Bello LJ, Lawrence WC. (1988) Comparison of the bovine herpesvirus 1 gI gene and the herpes simplex virus type 1 gB gene. J. Virol. 62: 3319–3327.
Misra V, Blewett EL. (1991) Construction of herpes symplex viruses that are pseudoploid for the glycoprotein B gene: a strategy for studying the function of an essential herpesvirus gene. J. Gen. Virol. 72: 385–392.
Misra V, Nelson R, Smith M. (1988) Sequence of a bovine herpesvirus type-1 glycoprotein gene that is homologous to the herpes simplex gene for glycoprotein B. Virology 166: 542–549.
Rauh I, Weiland F, Fehler F, Keil G, Mettenletter TC. (1991) Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J. Virol. 65: 621–631.
Kopp A, Mettenleiter TC. (1992) Stable rescue of a gIycoprotein gII deletion mutant of Pseudorabies virus by gIycoprotein gI of bovine herpesvirus 1. J. Virol 66: 2754–2762.
Fitzpatrick DR, Redmond MJ, Attah-Poku SK, van Drunen Littel-van den Hurk S, Babiuk LA, Zamb TJ. (1990) Mapping of 10 epitopes on bovine herpesvirus type 1 gIycoproteins gI and g III. Virology 176: 145–157.
Vlcek C, Benes V, Lu Z, et al. (1995) Nucleotide sequence analysis of a 30-kb region of the bovine herpesvirus 1 genome which exhibits a colinear gene arrangement with the UL21 to UL4 genes of herpes simplex virus. Virology 210: 100–108.
Wirth UV, Gunkel K, Engels M, Schwyzer M. (1989) Spatial and temporal distribution of bovine herpesvirus-1 transcripts. J. Virol. 63: 4882–4889.
Wirth UV, Gunkel K, Engels M, Schwyzer M. (1989) Spatial and temporal distribution of bovine herpesvirus 1 transcripts. J. Virol. 63: 4882–4889.
Seal BS, Whetstone CA, Zamb TJ, Bello LJ, Lawrence WC. (1992) Relationship of bovine herpesvirus 1 immediate-early, early and late gene expression to host cellular gene transcription. Virology 188: 152–159.
Fraefel C, Zeng J, Choffat Y, Engels M, Schwyzer M, Ackermann M. (1994) Identification and zinc dependence of the bovine herpesvirus 1 transactivator protein BICP0. J. Virol. 68: 3154–3162.
Singh M, Fraefel C, Bello LJ, Lawrence WC, Schwyzer M. (1996) Identification and characterization of BICP27, an early protein of bovine herpesvirus 1 which may stimulate mRNA 3′ processing. J. Gen. Virol. 77: 615–625.
Schwyzer M, Vlcek C, Menkse O, Fraefel C, Paces V. (1993) Promoter, spliced leader, and coding sequence for BICP4, the largest of the immediate-early proteins of bovine herpesvirus 1. Virology 197: 349–357.
Fraefel C, Ackermann M, Schwyzer M. (1994) Identification of the bovine herpesvirus-1 circ protein: a myristylated and virion-associated polypeptyde which is not essential for virus replication in cell culture. J. Virol. 68: 8082–8088.
Hammerschmidt W, Ludwig H, Buhk H-J. (1988) Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1. J. Virol. 62: 1355–1363.
Fraefel C, Wirth UV, Vogt B, Schwyzer M. (1993) Immediate-early transcription over covalently joined genome ends of bovine herpesvirus 1: the circ gene. J. Virol. 67: 1328–1333.
Misra V, Walker S, Hayes S, O’Hare P. (1995) The bovine herpesvirus a gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart V16. J. Virol. 69: 5209–5216.
Misra V, Bratanich AC, Carpenter D, O’Hare P. (1994) Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV)1 IE-1 transcription unit by the BHV α gene trans-inducing factor. J. Virol. 68: 4898–4909.
Huang CC, Herr W. (1996) Differential control of transcription by homologous homeodomain co-regulators. Mol. Cell. Biol. 16: 2967–2976.
Wirth UV, Vogt B, Schwyzer M. (1991) The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units. J. Virol. 65: 195–205.
van Drunen Littel-van den Hurk S, Garzon S, van den Hurk JV, Babiuk LA, Tijssen P. (1995) The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity. Virology 206: 413–425.
Wirth UV, Fraefel C, Vogt B, Vlcek C, Paces V, Schwyzer M. (1992) Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3′ coterminal and encode a putative zinc finger transactivator protein. J. Virol. 66: 2763–2772.
Huemer HP, Larcher C, van Drunen Littel-van den Hurk S, Babiuk L. (1993) Species selective interaction of Alphaherpesvirinae with the “unspecific” immune system of the host. Arch. Virol. 130: 354–364.
Jacobs L. (1994) Glycoprotein E of Pseudorabies virus and homologous proteins of other alphaherpesvirinae. Arch. Virol. 137: 209–228.
Hariharan MJ, Nataraj C, Srikumaran S. (1993) Down regulation of murine MHC class I expression by bovine herpesvirus 1. Viral Immunol. 6: 273–284.
Kutish G, Mainprize T, Rock D. (1990) Characterization of the latency-related transcriptionally active region of the bovine herpesvirus 1 genome. J. Virol. 64: 5730–5737.
Schang LM, Hossain A, Jones C. (1996) The latency-related gene of bovine herpesvirus-1 encodes a product which inhibits cell cycle progression. J. Virol. 70: 3807–3814.
Jiang Y, Hossain A, Winkler MT, Holt T, Doster A, Jones C. (1998) A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclindependent kinase 2 during productive infection. J. Virol. 72: 8133–8142.
Jones C, Delhon G, Bratanich A, Kutish G, Rock D. (1990) Analysis of the transcriptional promoter which regulates the latency-related transcript of bovine herpesvirus 1. J. Virol. 64: 1164–1170.
Bratanich AC, Jones CJ. (1992) Localization of cis-acting sequences in the latency-related promoter of bovine herpesvirus 1 which are regulated by memorial cell type factors and immediate-early genes. J. Virol. 66: 6099–6106.
Bratanich AC, Hanson ND, Jones CJ. (1992) The latency-related gene of bovine herpesvirus 1 inhibits the activity of immediate-early transcription unit 1. Virology 191: 988–991.
Devireddy LR, Jones C. (1998) Alternative splicing of the latency-related transcript of bovine herpesvirus 1 yields RNAs containing unique open reading frames. J. Virol 72: 7294–7301.
Schang LM, Jones C. (1997) Analysis of bovine herpesvirus 1 transcripts during a primary infection of trigeminal ganglia of cattle. J. Virol. 71: 6786–6795.
Whetstone CA, Miller IM, Seal BS, Bello LJ, Lawrence WC. (1992) Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch. Virol. 122: 207–214.
Rock D, Lokensgard J, Lewis T, Kutish G. (1992) Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. J. Virol. 66: 2484–2490.
van Engelenburg FAC, Kaashoek MJ, van Oirschot JT, Rijsewijk FAM. (1995) A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissue in calves as wild-type virus, but for a shorter period. J. Gen. Virol. 76: 2387–2392.
Bielefeldt O, Babiuk LA, Harland R. (1991) Cytokine synergy with viral cytopathic effects and bacterial products during the pathogenesis of respiratory tract infection. Clin. Immunol. Immunopathol. 60: 153–170.
Campos M, Bielefeldt Ohmann H, et al. (1989) Role of interferon-γ in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells. Cell. Immunol. 120: 259–269.
Hutchings DL, van Drunen Littel-van den Hurk S, Babiuk LA. (1990) Lymphocyte proliferative responses to separate bovine herpesvirus-1 proteins in immune cattle. J. Virol. 64: 5114–5122.
Babiuk LA, van Drunen Littel-van den Hurk S, Tikoo SK. (1996) Immunology of bovine herpesvirus 1 infection. Vet. Microbiol. 53: 31–42.
Choi S-H, Splitter GA. (1994) Induction of MHC-unrestricted cytolytic CD4+ T cells against virally infected target cells by cross-linking CD4 molecules. J. Immunol. 153: 3874–3881.
Denis M, Slaoui M, Keil G, et al. (1993) Identification of different target glycoproteins for bovine herpesvirus-1 specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology 78: 7–13.
Wang C, Splitter GA. (1998) CD4+ cytotoxic T-lymphocyte activity against macrophages pulsed with bovine herpesvirus 1 polypeptides. J. Virol. 72: 7040–7047.
Hanon E, Meyer G, Vanderplasschen A, Dessy-Doize C, Thiry E, Pastoret P-P. (1998) Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells. J. Virol. 72: 7638–7641.
Ryan AM, Womack JE. (1997) A molecular genetic approach to improved animal health. Vet. Clin. North Am: Food Anim. Pract. 13: 401–409.
Yu Z, Manickan E, Rouse BT. (1996) Role of interferon-γ in immunity to herpes simplex virus. J. Leukoc. Biol. 60: 528–532.
Milligan GN, Bernstein DI. (1997) Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229: 259–268.
Otsuka H, Qavi H, Kit S. (1982) Inhibition by interferon of biochemical transformation induced by cloned herpesvirus thymidine kinase genes. Antiviral Res. 2: 301–311.
Hughes HPA, Campos M, Godson DL, van Drunen Littel-van den Hurk S, McDougall L, Rapin N. (1991) Immunopotentiation of bovine herpesvirus subunit vaccination by interleukin-2. Immunology 74: 461–466.
Reddy PG, Blecha F, Minocha HC, et al. (1989) Bovine recombinant interleukin-2 augment immunity and resistance to bovine herpesvirus infection. Vet. Immunol. Immunopathol. 23: 61–74.
Hughes HPA, Campos M, van Drunen Littel-van den Hurk S, et al. (1992) Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with herpesvirus-1 glycoprotein IV. Vaccine 10: 226–230.
Reddy DN, Reddy PG, Minocha HC, et al. (1990) Adjuvancity of recombinant bovine interleukin-1β: influence on immunity, infection, and latency in bovine herpesvirus-1 infection. Lymphokine Res. 9: 295–307.
Reddy DN, Reddy PG, Xue W, Minocha HC, Daley MJ, Becha F. (1993) Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1β and interleukin-2. Vet. Immunol. Immunopathol. 37: 25–38.
Baca-Estrada ME, Godson DL, Hughes HPA, et al. (1995) Effect of recombinant bovine interleukin-1β on viral/bacterial pneumonia in cattle. J. Interferon Cytokine Res. 15: 431–439.
Leib DA, Olivo PD. (1993) Gene delivery to neurons: is herpes simplex virus the right tool for the job? Bioassays 15: 547–554.
Glorioso JC, DeLuca NA, Fink DJ. (1995) Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol. 49: 675–710.
Bello LJ, Whitbeck JC, Lawrence WC. (1992) Bovine herpesvirus 1 as live virus vector for expression of foreign genes. Virology 190: 666–673.
Kit M, Kit S, Little SP, Di Marchi RD, Gale C. (1991) Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) based viral vector which express foot-and-mouth disease epitopes. Vaccine 9: 564–572.
Kit S, Otsuka H, Kit M. (1992) Expression of porcine Pseudorabies virus genes by a bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) vector. Arch. Virol. 124: 1–20.
Otsuka H, Xuan X. (1996) Construction of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC and gE. Arch. Virol. 141: 57–71.
Ackermann M, Belak S, Bitsch V, et al. (1990) Round table on infectious bovine rhinotracheitis/infectious postural vulvovaginitis virus infection diagnosis and control. Vet. Microbiol. 23: 361–363.
Lemaire M, Schynts F, Meyer G, Thiry E. (1999) Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves. Vet Rec 144: 172–176.
Lemairie M, Meyer G, Ernst E, et al. (1995) Latent bovine herpesvirus 1 infection in calves protected by colostral immunity. Vet. Rec. 137: 70–71.
van Oirshot JT, Kaashoek MJ, Rijsewijk FAM. (1996) Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet. Microbiol. 53: 43–54.
Madin SH, York CJ, McKercher DG. (1956) Isolation of infectious bovine rhinotracheitis virus. Science 124: 721–722.
Kendrick JW, York CJ, McKercher DG. (1956) A controlled field trial of a vaccine for infectious bovine rhinotracheitis. Proc. U.S. Livestock San. Assoc. 60: 155–158.
Straub OC, Mawhinney IC. (1988) Vaccination to protect calves against infectious bovine rhinotracheitis. Vet. Rec. 122: 407–411.
Zygraich N, Lobmann M, Vascoboinic E, Berge E, Huygelen C. (1974) In vivo and in vitro properties of a temperature sensitive mutant in infectious bovine rhinotracheitis virus. Res. Vet. Sci. 16: 328–335.
Whetstone CA, Wheeler JG, Reed DE. (1986) Investigation of possible vaccine induced epizootics of infectious rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am. J. Vet. Res. 47: 1789–1795.
Whetstone C, Miller J, Bortner D, van Der Maaten MJ. (1989) Changes in the restriction endonuclease patterns of four modified-live infectious bovine rhinotracheitis virus (IBRV) vaccines after one passage in host animal. Vaccine 7: 527–532.
Duque H, Marshall RL, Israel BA, Letchworth GJ. (1989) Effect of formalin inactivation on bovine herpesvirus 1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits. Vaccine 7: 513–520.
Brun A, Dauvergine M, Languet B, Reynaud G. (1988) Studies of an inactivated vaccine prepared from viral subunits against infectious bovine rhinotracheitis virus. Med. Vet. 5: 583–586.
Frerichs GN, Woods SB, Lucas MH, Sands J-J. (1982) Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines. Vet. Rec. 111: 116–122.
Bryan LA, Fenton RA, Misra V, Haines DM. (1994) Fatal, generalized bovine herpesvirus type 1 infection associated with a modified-live infectious bovine rhinotracheitis parainfluenza-3 vaccine administered to neonatal calves. Can. Vet. J. 35: 223–228.
Backer JC, Rust RS, Walker RD. (1989) Transmission of a vaccinal strain of infectious bovine rhinotracheitis virus from intranasally vaccinated steers commingled with non vaccinated steers. Am. J. Vet. Res. 50: 814–816.
Pastoret P-P, Babiuk LA, Misra V, Griebel P. (1980) Reactivation of temperature-sensitive and non-temperature sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. Infect. Immunol. 29: 483–488.
George LW, Ardans A, Mihalyi S, Guerra MR. (1988) Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine. Am. J. Vet. Res. 49: 1800–1806.
Kelling CL, Schipper IA, Strum GE, Carlson RB, Tilton GE. (1973) Infectious bovine rhinotracheitis (IBR) abortion; observations on incidence in vaccinated and non-vaccinated and exposed cattle. Cornell Vet. 63: 383–389.
van Der Maaten MJ, Miller JM, Whetstone CA. (1985) Ovarian lesions induced in heifers by intravenous inoculation with modified-live infectious bovine rhinotracheitis virus on the day after breeding. Am. J. Vet. Res. 46: 1996–1999.
Smith PC, Nusbaum KE, Kwapien RP, Stringfellow DA, Driggers K. (1990) Necrotic oophoritis in heifers vaccinated intravenously with infectious bovine rhinotracheitis virus vaccine during estrus. Am. J. Vet. Res. 51: 969–972.
Harasawa R. (1995) Advention pestivirus RNA in live virus vaccine against bovine and swine diseases. Vaccine 13: 100–103.
Babiuk LA, L’Italien J, van Drunen Littel-van den Hurk S, et al. (1987) Protection of cattle from bovine herpesvirus type-1 (BHV-1) infection by immunization with individual glycoproteins. Virology 159: 57–66.
Van Drunen Littel-van den Hurk S, van Den Hurk JV, Gilchrist JE, Misra V, Babiuk LA. (1984) Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135: 466–479.
Collins JK, Butcher AC, Riegel CA. (1985) Immune response to bovine herpesvirus type-1 infections: virus-specific antibodies in sera from infected animals. J. Clin. Microbiol. 21: 546–552.
Ayers VK, Collins JK, Purdy CW. (1994) Epitope-specific antibody responses in market-stressed calves to bovine herpesvirus type 1. Vaccine 12: 940–946.
Israel BA, Marshall RL, Letchworth GL. (1988) Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 gIycoprotein vaccine. Vaccine 6: 349–356.
Kaashoek MJ, Moerman A, Madic J, et al. (1995) An inactivated vaccine based on a glycoprotein gE-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13: 342–346.
Zhu X, Letchworth GJ. (1996) Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle. Vaccine 14: 61–69.
Babiuk LA, van Drunen Littel-van den Hurk S, Tikoo SK, Lewis PJ, Liang X. (1996) Novel viral vaccines for livestock. Vet. Immunol. Immunopathol. 54: 355–363.
Fitzpatrick DR, Zamb T, Parker MD, van Drunen Littel-van den Hurk S, Babiuk LA, Lawman MJP. (1988) Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. J. Virol. 62: 4239–4248.
van Drunen Littel-van den Hurk S, Zamb TJ, Babiuk LA. (1989) Synthesis, cellular location and immunogenicity of bovine herpesvirus-1 glycoproteins gI and gIII expressed by recombinant vaccinia virus. J. Virol. 63: 2159–2168.
Leary TP, Gao Y, Splitter GA. (1992) Constitutively expressing cell lines which secrete bovine herpesvirus-1 glycoprotein I stimulate T lymphocyte responsiveness. Immunology 76: 367–372.
van Drunen Littel-van den Hurk S, Parker MD, Massie B, van den Hurk JV, Harland R, Babiuk LA. (1993) Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11: 25–36.
van Drunen Littel-van den Hurk S, Parker MD, Fitzpatrick DR, et al. (1991) Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties. J. Virol. 65: 263–271.
van Drunen Littel-van den Hurk S, van Donkersgoed J, Kowalski J, et al. (1994) A subunit gIV vaccine produced by transfected mammalian cells in culture, induces mucosa immunity against bovine herpesvirus-1 in cattle. Vaccine 12: 1295–1302.
Merza M, Tibor S, Kucsera L, Bognar G, Morein B. (1991) ISCOM of BHV-1 envelope glycoproteins protected calves against both disease and infection. J. Vet. Med. 38: 306–314.
Garcia-Valcarcel M, Fowler WJ, Harper DR, Jeffries DJ, Layton GT. (1997) Cloning, expression and immunogenicity of the assembly protein of varicella-zoster virus and detection of the products of open reading frame 33. J. Med. Virol. 53: 332–339.
Trudel M, Nadon F, Seguin C, Boulay G, Lussier G. (1987) Vaccination of rabbits with a bovine herpesvirus type 1 subunit vaccine: adjuvant effect of ISCOMs. Vaccine 5: 239–243.
Moser CA, Speaker TJ, Offit PA. (1997) Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice. Vaccine 15: 1767–1772.
Young PL, Smith GA. (1995) Genetically altered herpesviruses as vaccines. Vet. Microbiol. 46: 175–179.
Rijsewijk FAM, Kaashoek MJ, Keil G, et al. (1994) In vitro and in vivo phenotypes and immunogenic properties of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI or gE gene. In: Proceedings of the 19th Herpesvirus Workshop, Vancouver, July 30-August 5, p. 419.
Kit S, Qavi H, Gaines JD, Billingsley P, McConnell S. (1985) Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch. Virol. 86: 63–83.
Smith GA, Young PL, Rodwell BJ, et al. (1994) Development and trial of a bovine herpesvirus-1-thymidine kinase deletion virus as a vaccine. Austr. Vet. J. 71: 65–70.
Yu-Su K, Liu C, Manning J-RS. (1986) Identification of the thymidine kinase gene of infectious bovine rhinotracheitis virus and its function in Escherichia coli hosts. Gene 44: 279–285.
Bello L, Whitbeck JC, Lawrence WC. (1987) Map location of the thymidine kinase gene of bovine herpesvirus 1. J. Virol. 61: 4023–4025.
Kaashoek MJ, Moerman A, Madic J, et al. (1994) A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12: 439–444.
van Oirschot JT. (1994) Vaccination in food animal population. Vaccine 12: 415–418.
Kaashoek MJ, van Engelenburg FAC, Moerman A, Gielkens ALJ, Rijsewijk FAM, van Oirschot JT. (1996) Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Vet. Microbiol. 48: 143–153.
Flores EF, Osorio FA, Zanella EL, Kits S, Kit M. (1993) Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals. J. Vet. Diagn. Invest. 5: 534–540.
Bosch JC, Frankena K, van Oirschot JT. (1996) Effect on milk production of vaccination with a bovine herpesvirus 1 gene-deleted inactivated vaccine. Vet. Rec. 140: 196–199.
Strube W, Auer S, Block W, et al. (1996) A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Vet. Microbiol. 53: 181–189.
Denis M, Hanon E, Rijsewijk FAM, et al. (1996) The role of glycoproteins gC, gE, gI and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1. Vet. Microbiol. 53: 121–132.
Chowdhury SI. (1996) Construction and characterization of an attenuated bovine herpesvirus type 1 (BHV-1) recombinant virus. Vet. Microbiol. 52: 13–23.
Kuhnle G, Collins RA, Scott JE, Keil M. (1996) Bovine interleukins 2 and 4 expressed in recombinant bovine herpesvirus 1 are biologically active secreted glycoproteins. J. Gen. Virol. 77: 2231–2240.
Dinarello CA. (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627–1652.
Raggo C, Fitzpatrick DR, Babiuk LA, Liang X. (1996) Expression of bovine interleukin-1 β in a bovine herpesvirus-1 vector: in vitro analysis. Virology 221: 78–86.
Cox GJM, Zamb TJ, Babiuk LA. (1993) Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67: 5664–5667.
Terpstra C, Kroese AH. (1996) Potency control of modified live vaccines for veterinary use. Vaccine 14: 13–18.
Strube W, Abar B, Bergle RD, et al. (1995) Safety aspects in the development of an infectious bovine rhinotracheitis marker vaccine. Dev. Biol. Stand. 84: 75–81.
Mettenleiter TC. (1996) Conclusions from the symposium. Vet. Microbiol. 53: 207–211.
van Drunen Littel-van den Hurk S, Khattar S, Tikoo SK, et al. (1996) Glycoprotein H (gII/gp108) and glycoprotein L form a functional complex which plays a role in penetration, but not in attachment, of bovine herpesvirus 1. J. Gen. Virol. 11: 1515–1520.
Baranowski E, Dubuisson J, van Drunen Littelvan den Hurk S, et al. (1995) Synthesis and processing of bovine herpesvirus-1 glycoprotein H. Virology 206: 651–654.
Chowdhury SI. (1997) Fine mapping of bovine herpesvirus 1 (BHV-1) glycoprotein C neutralizing epitopes by type-specific monoclonal antibodies and synthetic peptides. Vet. Microbiol. 58: 309–314.
Keil GM, Engelhardt T, Karger A, Enz M. (1996) Bovine herpesvirus 1 Us open reading frame 4 encodes a glycoproteoglycan. J. Virol. 70: 3032–3038.
Kuhnle G, Heinze A, Schmitt J, et al. (1998) The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1. J. Virol. 72: 3804–3811.
Khadr A, Tikoo SK, Babiuk LA, van Drunen Littel-van den Hurk S. (1996) Sequence and expression of a bovine herpesvirus-1 gene homologous to the glycoprotein K-encoding gene of herpes simplex virus-1. Gene 168: 189–193.
Wu SX, Zhu XP, Letchworth GJ. (1998) Bovine herpesvirus 1 glycoprotein M forms a disulfidelinked heterodimer with the UL 49.5 protein. J. Virol. 72: 3029–3036.
Khattar SK, van Drunen Littel-van den Hurk S, Attah-Poku SK, Babiuk LA, Tikoo SK. (1996) Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH. Virology 219: 66–76.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Turin, L., Russo, S. & Poli, G. BHV-1: New Molecular Approaches to Control a Common and Widespread Infection. Mol Med 5, 261–284 (1999). https://doi.org/10.1007/BF03402063
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03402063